Clinical Outcomes and Impact of Therapeutic Intervention in Patients With Acute Myeloid Leukemia Who Experience Measurable Residual Disease (MRD) Recurrence Following MRD-Negative Remission

Authors

Nicholas J Short
Walid Macaron
Tapan Kadia
Courtney Dinardo
Ghayas C Issa
Naval Daver
Sa Wang
Jeff Jorgensen
Daniel Nguyen
Aram Bidikian
Keyur P Patel
Sanam Loghavi
Marina Konopleva
Musa Yilmaz
Elias Jabbour
Abhishek Maiti
Hussein A Abbas
Elizabeth Shpall
Uday Popat
Gheath Al-Atrash
Sherry Pierce
Hagop M Kantarjian
Farhad Ravandi

Publication Date

11-1-2022

Journal

American Journal of Hematology

DOI

10.1002/ajh.26698

PMID

36054774

PubMedCentral® Full Text Version

Post-print

Abstract

Recurrence of MRD in AML is associated with imminent relapse unless intervened upon. Change in chemotherapy regimen and/or immediate transplant improve outcomes.

Keywords

Hematopoietic Stem Cell Transplantation, Humans, Leukemia, Myeloid, Acute, Neoplasm, Residual, Prognosis, Recurrence

Published Open-Access

yes

Recommended Citation

Short, Nicholas J; Macaron, Walid; Kadia, Tapan; et al., "Clinical Outcomes and Impact of Therapeutic Intervention in Patients With Acute Myeloid Leukemia Who Experience Measurable Residual Disease (MRD) Recurrence Following MRD-Negative Remission" (2022). Faculty, Staff and Student Publications. 4194.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/4194